Mamilla, Marcos M.

HRN: 20-99-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2022
CEFTRIAXONE 1G (VIAL)
09/26/2022
10/05/2022
IV
2g
OD
Cellulitis
Waiting Final Action 
09/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/26/2022
10/09/2022
IV
600mg
Q6
Cellulitis
Waiting Final Action 
09/29/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/29/2022
10/05/2022
IV
1.5g
Q6
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: